Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

PML: Regulation and multifaceted function beyond tumor suppression.

Hsu KS, Kao HY.

Cell Biosci. 2018 Jan 25;8:5. doi: 10.1186/s13578-018-0204-8. eCollection 2018. Review. Erratum in: Cell Biosci. 2018 Mar 6;8:18.

2.

Effects of Y361-auto-phosphorylation on structural plasticity of the HIPK2 kinase domain.

Scaglione A, Monteonofrio L, Parisi G, Cecchetti C, Siepi F, Rinaldo C, Giorgi A, Verzili D, Zamparelli C, Savino C, Soddu S, Vallone B, Montemiglio LC.

Protein Sci. 2018 Mar;27(3):725-737. doi: 10.1002/pro.3367. Epub 2017 Dec 28.

PMID:
29277937
3.

TRIM8: Making the Right Decision between the Oncogene and Tumour Suppressor Role.

Caratozzolo MF, Marzano F, Mastropasqua F, Sbisà E, Tullo A.

Genes (Basel). 2017 Nov 28;8(12). pii: E354. doi: 10.3390/genes8120354. Review.

4.

Conserved structural and functional aspects of the tripartite motif gene family point towards therapeutic applications in multiple diseases.

Gushchina LV, Kwiatkowski TA, Bhattacharya S, Weisleder NL.

Pharmacol Ther. 2018 May;185:12-25. doi: 10.1016/j.pharmthera.2017.10.020. Epub 2017 Oct 31. Review.

PMID:
29097306
5.

The IGF-1R/AKT pathway determines cell fate in response to p53.

Duan L, Maki CG.

Transl Cancer Res. 2016 Dec;5(6):664-675. doi: 10.21037/tcr.2016.09.16.

6.

GLYAT regulates JNK-mediated cell death in Drosophila.

Ren P, Li W, Xue L.

Sci Rep. 2017 Jul 12;7(1):5183. doi: 10.1038/s41598-017-05482-y.

7.

Crosstalk between NRF2 and HIPK2 shapes cytoprotective responses.

Torrente L, Sanchez C, Moreno R, Chowdhry S, Cabello P, Isono K, Koseki H, Honda T, Hayes JD, Dinkova-Kostova AT, de la Vega L.

Oncogene. 2017 Nov 2;36(44):6204-6212. doi: 10.1038/onc.2017.221. Epub 2017 Jul 10.

8.

Variant 2 of KIAA0101, antagonizing its oncogenic variant 1, might be a potential therapeutic strategy in hepatocellular carcinoma.

Liu L, Liu Y, Chen X, Wang M, Zhou Y, Zhou P, Li W, Zhu F.

Oncotarget. 2017 Jul 4;8(27):43990-44003. doi: 10.18632/oncotarget.16702.

9.

PML nuclear bodies contribute to the basal expression of the mTOR inhibitor DDIT4.

Salsman J, Stathakis A, Parker E, Chung D, Anthes LE, Koskowich KL, Lahsaee S, Gaston D, Kukurba KR, Smith KS, Chute IC, Léger D, Frost LD, Montgomery SB, Lewis SM, Eskiw C, Dellaire G.

Sci Rep. 2017 Mar 23;7:45038. doi: 10.1038/srep45038.

10.

Homeodomain-interacting protein kinase 2 (HIPK2): a promising target for anti-cancer therapies.

Feng Y, Zhou L, Sun X, Li Q.

Oncotarget. 2017 Mar 21;8(12):20452-20461. doi: 10.18632/oncotarget.14723. Review.

11.

HIPK2-T566 autophosphorylation diversely contributes to UV- and doxorubicin-induced HIPK2 activation.

Verdina A, Di Rocco G, Virdia I, Monteonofrio L, Gatti V, Policicchio E, Bruselles A, Tartaglia M, Soddu S.

Oncotarget. 2017 Mar 7;8(10):16744-16754. doi: 10.18632/oncotarget.14421.

12.

Otub1 stabilizes MDMX and promotes its proapoptotic function at the mitochondria.

Chen Y, Wang YG, Li Y, Sun XX, Dai MS.

Oncotarget. 2017 Feb 14;8(7):11053-11062. doi: 10.18632/oncotarget.14278.

13.

Hyperglycemia triggers HIPK2 protein degradation.

Baldari S, Garufi A, Granato M, Cuomo L, Pistritto G, Cirone M, D'Orazi G.

Oncotarget. 2017 Jan 3;8(1):1190-1203. doi: 10.18632/oncotarget.13595.

14.

Arsenic-Induced Activation of the Homeodomain-Interacting Protein Kinase 2 (HIPK2) to cAMP-Response Element Binding Protein (CREB) Axis.

Hashimoto K, Tsuji Y.

J Mol Biol. 2017 Jan 6;429(1):64-78. doi: 10.1016/j.jmb.2016.11.015. Epub 2016 Nov 21.

15.

PARP1 regulates the protein stability and proapoptotic function of HIPK2.

Choi JR, Shin KS, Choi CY, Kang SJ.

Cell Death Dis. 2016 Oct 27;7(10):e2438. doi: 10.1038/cddis.2016.345.

16.

Homeodomain-Interacting Protein Kinase-2: A Critical Regulator of the DNA Damage Response and the Epigenome.

Kuwano Y, Nishida K, Akaike Y, Kurokawa K, Nishikawa T, Masuda K, Rokutan K.

Int J Mol Sci. 2016 Sep 27;17(10). pii: E1638. Review.

17.

Molecular signaling cascades involved in nonmelanoma skin carcinogenesis.

Feehan RP, Shantz LM.

Biochem J. 2016 Oct 1;473(19):2973-94. doi: 10.1042/BCJ20160471. Review.

18.

HIPK2 modification code for cell death and survival.

Wook Choi D, Yong Choi C.

Mol Cell Oncol. 2014 Oct 29;1(2):e955999. doi: 10.1080/23723548.2014.955999. eCollection 2014 Apr-Jun. Review.

19.

Mitochondrial death functions of p53.

Marchenko ND, Moll UM.

Mol Cell Oncol. 2014 Oct 31;1(2):e955995. doi: 10.1080/23723548.2014.955995. eCollection 2014 Apr-Jun. Review.

20.

Ras signaling through RASSF proteins.

Donninger H, Schmidt ML, Mezzanotte J, Barnoud T, Clark GJ.

Semin Cell Dev Biol. 2016 Oct;58:86-95. doi: 10.1016/j.semcdb.2016.06.007. Epub 2016 Jun 8. Review.

Supplemental Content

Support Center